| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
68 |
| Employees |
357 |
| Revenues (TTM) (Millions $) |
172 |
| Net Income (TTM) (Millions $) |
-19 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
18 |
Business Description
GenMark Diagnostics Inc. is a leading molecular diagnostics company that develops and commercializes high-accuracy, easy-to-use multiplex molecular tests that detects infectious diseases, genetic conditions as well as cancer. The company is headquartered in Carlsbad, California, and it was founded in 2010.
The company specializes in developing molecular diagnostic solutions that use its proprietary eSensore detection technology, which is a microelectronic sensor that can detect and identify multiple genetic targets within a single sample. This technology provides highly accurate, actionable results that can guide physicians in making informed patient care decisions.
GenMark Diagnostics' products are used in hospitals, reference labs, and specialty clinics. The company's flagship product is the ePlexe system, which is a fully integrated, automated, and scalable multiplex system that can detect up to 24 analytes from a single patient sample. The ePlexe system can process samples in less than 2 hours and has a high degree of accuracy, which makes it an industry-leading offering.
In addition to its ePlexe system, GenMark Diagnostics also offers a range of other products, including the eSensore XT-8 and the XT-8 systems. These products are designed for use in infectious disease testing, genetic testing, and oncology testing.
GenMark Diagnostics' team of experienced professionals includes scientists, engineers, and sales and marketing experts who bring deep expertise in developing and commercializing advanced molecular diagnostic solutions. The company has partnerships with leading healthcare organizations, reference labs, and industry organizations that help it to build a strong presence in the market.
Overall, GenMark Diagnostics is known for developing innovative, high-accuracy, and easy-to-use diagnostic solutions that help clinicians to diagnose and treat infectious diseases, genetic conditions, and cancer. The company's advanced eSensore technology and its range of proprietary products have made it a leader in the molecular diagnostics market.
Company Address: 5964 La Place Court Carlsbad 92008 CA
Company Phone Number: 448-4300 Stock Exchange / Ticker: NASDAQ GNMK
|
%